• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

image

PLAY BUTTON

image

PLAY BUTTON

image

Progress

1/267

Click to flip

267 Cards in this Set

  • Front
  • Back
Glasgow Coma Scale
assess LOC, verbal and motor ability; scale 3-15; higher the better, <8 = coma
Intracranial space components
brain tissue, blood, CSF
NORM ICP
5-15 mmHg
Causes for transient increase in ICP
sneezing, straining, defecation, coughing, blowing nose
Early sign of IICP
vision; diplopia, blurred, lower acuity
Later signs of IICP
personality change, thought process change, h/a, N
Cause of IICP
compliance and accommodation fails with increasing volume in intracranial space
Cascade of IICP effects
IICP-> dec. cerebral perfusion -> tissue hypoxia, lower pH, inc. CO2
Tests for IICP
CT(cause), MRI
Medical management of IICP
craniotomy, craniectomy, tumor removal, drain ventricles, drain hematoma, intubation
Medication management of IICP
osmotic diuretics, loop diuretics, corticosteroids, antipyretics, anticonvulsants, histamine antagonists, barbiturates
COA of osmotic diuretics for Tx of IICP
lowers ICP by inc. blood osmolality, draws blood from edemitus brain tissue into vascular circulation
COA of antipyretics for Tx of IICP
controls hyperthermia (which increases metabolic rate in brain)
COA of histamine antagonists for Tx of IICP
lowers risk of stress ulcers
COA of barbiturates for Tx of IICP
barbiturate-induced coma; lowers metabolic demand of tissue
Nursing interventions to improve cerebral perfusion
elevate HOB 30 degrees, avoid valsalva's, quiet environment (lower stress), cluster activity (provide rest periods), restrict fluids, avoid freq. suctioning, O2, hypothermia blanket
Define seizure
excessive and abnormal transient electrical activity within the brain usually resulting in involuntary body movements
Causes of seizures
idiopathic, hypoglycemic, electrolyte imbalance (hyperkalemia), trauma, infection, IICP, toxins
1/2 of all seizures
idiopathic
Partial seizures
do not always involve loss of conciousness, may develop into generalized seizures
Simple partial seizure
1 hemisphere, uncontrolled movement, Pt has memory of incident and can interact during seizure
Complex partial seizure (psychomotor)
inappropriate behaviors, effects LOC, often includes feeling an "aura" prior, common to have amnesia about event
Generalized seizure
usually affects LOC
Absence seizure
type of generalized seizure; 5-30 sec., can have >100/day, no movement, unresponsive, "daydreaming", can be commonly found in kids
Tonic-clonic seizure
type of generalized seizure; periods of rhythmic jerking and relaxation
"tonic" period
15-60 sec.; may see cyanosis, cease to breath, urinary/bowel incontinence
"clonic" period
60-90 sec.; jerking, eyes roll back in head, hyperventilation
postictal phase of tonic-clonic seizure
quiet, relaxed, no movement, not concious, eventually wakes confused
Atonic seizure
type of generalized seizure; sudden loss of tone in muscle, collapse/fall or dropping object, may have brief loss of conciousness, no postictal phase
Status epilepticus
emergency; prolonged seizure or several seizures right after eachother lasting >30min.
List anticonvulsants/seizure medications
dilantin, valium, depakene, neurontin, tegrital
Seizure precautions
low bed position, padded side rails, side rails up, IV access, O2 and suction equipment ready
Precautions during seizure
lower Pt to floor, pillow under head, do not restrain, no tongue blade, prevent aspiration by turning on side, loosen clothing around neck, document
Describe MS
AI disease effecting the myelin sheath, causing slow/loss of nerve conduction expressed through exacerbations/remissions
Subjective MS s/s
wide range depending on loc. or myelin damage- shaking, weakness, numb, tinnitus, visual s/s, difficult chewing and walking, incontinent, impotent
Objective MS s/s
ataxia, behavior change, nystagmus, spasticity, tremors, dysphagia, palsy, impaired speech, incontinence, impaired judgement
Dx tools for MS
CSF (inc. protein, WBC, and IgG), MRI (plaques), CT (plaques), visual/auditory/brainstem evoked potential, electromyography
MS meds (types)
corticosteroids, muscle relaxers, immunosupressants, immunomodulators
Corticosteroids- action
reduce edema and inflammatory response during exacerbations
Corticosteroids- types
ACTH, Solu Medrol, Prednisone
Muscle Relaxers- action
reduces muscle spasticity
Muscle Relaxants- types
Baclofen, Dantrolene, Valium
Immunosuppressants- action
stability disease (MS) process
Immunosuppressants- types
Imuran, Cytoxan
Immunomodulators- action
slows disease (MS) progression
Immunomodulators- types
Avonex, Betaseron, Copaxone
MS Nursing Interventions
inc. energy in morning, rest/relaxation periods, maintain constant temp., set priorities, pace activities, adaptive devices
describe Parkinson's
a chronic degenerative disease of neurons of the basal ganglia, causing a deficiency in dopamine
1st s/s of Parkinson's
fatigue, problems w/dexterity, minor tremors
Other s/s Parkinson's
muscle rigidity, "pill rolling", uncoordination, stooped posture, shuffling gait, mask-like face, dysphagia, drooling, monotone, dementia, akinesia/bradykinesia
Dx Parkinson's
no test; based on symptoms and response to med
Parkinson's Meds (types)
dopaminergics, dopamine agonists, monoamine oxidase inhibitors, anticholinergics
Dopaminergics- action
inc. mobility by red. tremors and rigidity, increases dopamine release
Dopaminergics- types
levodopa, sinemet, symmetrel
Dopamine agonists- action
activates dopamine receptors (used in conj. w/dopaminergics)
Dopamine agonists- types
parlodel, permax, mirapex, requip
MAOI- action
used early in Parkinson's, blocks dopamine metabolism
MAOI- types
eldepryl
Anticholinergics- action
eases drooling, tremors, rigidity
Anticholinergics- types
artane, cogentin, parsidol, akineton
Parkinson's Nursing Interventions
ROM, ambulate 4xday, assistive devices, speech pathologist, OT, food consistencies, sleep-wake cycle, strategies to promote sleep
Describe Myasthenia Gravis
AI disease affecting ACh receptors at the neuromuscular junction
Early s/s of MG
ptosis, diplopia
Other s/s of MG
weakness, dysarthria, dysphagia, difficulty sitting, resp. distress
Dx MG
+ tensilon test, EMG, ACh receptor Ab serum levels
MG medications- types
Anticholinesterases, immunosuppressives, procedures
Anticholinesterases- action
allows ACh to collect @ neuromuscular junction @ ACh receptor sites; promotes muscle contraction
Anticholinesterases- types
mestinon, prostigmin, mytelase
Immunosuppressives- action
improves strength, reduces inflammation
Immunosuppressives- types
prednisone, imuran (lowers ACh Ab in months)
Procedures to treat MG
plasmaphoresis, thymectomy (40% remmission w/ Pt<40 y/o)
MG Nursing Interventions
assist w/turning, coughing, incentive spir., semi-fowler's, hydrate (<2500), food consistencies, meal/med sched., small bites, know heimlich
Myasthenic crisis
caused by low ACh, stress, or infection, exacerbation of MG s/s, respiratory arrest
Cholinergic crisis
toxic rxn to percription, too much ACh, causing sudden extreme weakness, respiratory arrest
Distinguishing factor b/t myasthenic and cholinergic crisises
Myasthenic crisis = + tensilon test
Amyotrophic lateral sclerosis
lou gehrig's disease; chronic, rapidly progressing degenerative disease of motor neurons, causing eventual paralysis of resp. muscles
early ALS s/s
weakness, fasciculations, uncoordinated, spasticity, paresis, hyperreflexia, atrophy
other ALS s/s
dysarthria, dyspnea, difficulty coughing and chewing, dysphagia, emotional, loss of control
ALS prognosis
50% die in 2-5 yrs following Dx due to resp. failure or aspiration pn.
Dx of ALS
EMG, muscle biopsy, mostly process of elimination
ALS nursing interventions
ROM q2hr, + N balance, hydrate, monitor infection, assist turning, coughing, incentive spir., turn q2hr, elevate HOB >30, suction, oxygen
Describe Huntington's disease
genetically dominant inherited degenerative disease of the nervous system; ex. woody guthrie
early Huntington's motor s/s
restless, fidgety, gait and posture changes, protruding tongue, slurred speech
late Huntington's motor s/s
chorea, grimacing, dysphagia, unintelligible speech, impaired diaphragmatic movement, resp. problems
early Huntington's psychosocial s/s
irritability, outbursts, dperession, risk for suicide
late Huntington's psychosocial s/s
decreased memory, loss of cognition, dementia, total dependence
Dx of Huntington's
genetic tests
Huntington's meds
antipsychotics (block dopamine rec.) and antidepressants
Huntington's nursing interventions
upright positioning, heimlich, thickened food consistency, calm env., continue feeding when turns head away, high cal snacks/food, avoid milk, adaptive tools, oral hygeine, alternative/therapeutic communication
Describe Alzheimer's
progressive, degenerative form of dementia causing a deterioration of general intellect
1st stage Alzheimer's
still alert, memory lapses, subtle personality changes, dec. attention span, restless, forgetful, congitive deficits
2nd stage Alzheimer's
more memory problems, disoriented to time/place, language deficits (paraphasia, eccolalia, scanning speech), sensorimotor deficits (apraxia, astereognosis, agraphia), wandering, periods of lucidity
apraxia
unable to do purposeful movements or use objects properly
astereognosis
inability to identify objects by touch
agraphia
inability to write
paraphasia
using the wrong word
eccolalia
repition of same words/phrases
scanning speech
searching for the words
3rd stage Alzheimer's
total disorientation, inability to communicate, incontinent, loss of cognition
stage 3 Alzheimer's complications/risks
pneumonia, dehydration, falls, paranoia
Dx Alzheimer's
no test; EEG pattern, MRI/CT (hippocampus shrink), PET, folstein's mini-mental status exam, fam Hx, autopsy
Alzheimer's prognosis
7 yrs from Dx
Alzheimer's meds- types
cholinesterase inhibitors, tranquilizers, supplements, complementary therapies
cholinesterase inhibitors- types
for mild-mod dementia; cognex, aricept, exelon
tranquilizers- types
for aggitation; mellaril, haldol
Alzheimer's supplements
vit c & e, folic acid, vitamin B12
Alzheimer's complementary therapies
massage, herbs (gingko), coenzyme Q10, art/music/dance therapy
Alzheimer's Nursing interventions
calenders, lists, alarms, med boxes, safety in kitchen, program emergency phone #s, life-line, labels, remove toxins/hazards, min. stimuli, ID self every time and orient, repeat, boundaries, continuity [caregiver role strain]
describe Guillain-Barre
AI disorder causing muscle weakness and paralysis
GB s/s
flaccid paresthesias, symmetric LE weakness, progressive weakness to UE and face, possible resp. arrest
Dx GB
physical exam, Hx, CSF (inc. protein, norm cell count), EMG studies
GB meds
analgesics, antibiotics, anticoagulents, vasopressors (if HTN)
Procedure r/t GB
tracheostomy, plasmaphoresis
describe TIA
brief attack of localized cerebral ischemia lasting <24 hrs, considered a warning sign for CVA
cause for CVA
dec. blood flow to brain by ischemia or hemorrhage
CVA motor s/s
opposite side effects, balance, coordination, gait, proprioception
CVA sensory s/s
aphasia, agnosia, apraxia, neglect syndrome, visual difficulty
CVA cognitive s/s
denial, impaired memory/judgement, unable to concentrate, disoriented, slow and cautious, depressed and anxious, angers quickly
CVA Dx
CT w/o contrast, MRI, cerebral angiogram
CVA meds
thrombolytics (w/in 3 hrs), antiplatelets/anticoagulants (contraindicated for hemorrhagic), corticosteroids, anticonvulsants, carotid endarterectomy, aneurysm repair
Races at greater risk for DM
AA, NA, hispanic/LA
DM complications
leading cause of heart disease, stroke, adult blindness, end stage renal failure, non-traumatic LE amputation
glucagon
produced by alpha cells in pancreas, stimulates glycogenolysis, increasing BG levels
somatostatin
produced by delta cells of pancreas, inhibits glucagon and insulin secretion, maintaining current BG levels
Type 1 DM
AI disease where beta cells are destroyed, absolute insulin deficient; 5-10% of cases, usually <25 y/o, "juvenile onset" or "insulin dep."
Type 2 DM
no beta cell destruction, insufficient insulin prod. or cell resistence to insulin; 90% of cases, usually >40 y/o, "adult onset" or "non- insulin dependent"
Gestational D
transitory glucose intolerance; 2-5% of pregnancies
Etiology of Type 1 DM
genetic predisposition + environmental trigger, AI, more common in the young and men
s/s of Type 1 DM
polyuria, polydipsia, polyphagia, glycosuria, weight loss, malaise, fatigue, blurred vision
Etiology of Type 2 DM
genetic predisposition, advancing age, obesity, inactivity, race/ethnicity, more common in women than men, pregnancy, baby >9lbs, polycystic ovary syndrome
s/s of Type 2 DM
usually asymptomatic, hyperglycemia, polyuria, polydipsia, blurred vision, fatigue, paresthesias, prolonged healing, recurrent skin/vaginal infection
Casual plasma DM Dx test
casual BG taken any time of day w/out regard to last meal, activity, etc.; >200
Fasting plasma DM Dx test
fasting (>8 hr) glucose level >126
Glucose tolerance test for DM Dx
glucose bolus of 75 g, in 2 hrs, BG>200
Requirement to Dx DM
positive one of 3 tests + a positive result of different test on different day
Glycoslylated hemoglobin test ranges
<7%= good control, 7-9%= fair control, >9%=poor control
glycosylated hemoglobin test action
glucose permanently attaches to Hgb, the more glucose in blood, the more glycosylated Hgb, not effected by meals, time of day, drugs, stress, activity; shows diabetic control for last 100 days
urine glucose test
when renal glucose threshold exceeded; 180-200 BG level
urine ketone test
when fatty acids are being metabolized for energy
microalbumin test
indicates pending ketoacidosis
need to take a diabetes monitoring test when...
diabetic is ill, stressed, any s/s, or BG level >300
5 componenets of diabetes management
diet, exercise, medications, self-monitoring of BG, and education
diabetic diet; cals from carbs
60-70%
diabetic diet; cals from protein
15-20%
diabetic diet; cals from fat
<10%
diabetic diet; fiber
20-35 g/day
diabetic diet; sodium
1000-3000 mg/day MAX
diabetic diet; alcohol
men: <2 drinks/day
women: <1 drink/day
alcohol potentiates the hypoglycemic effect of insulin or other diabetic meds
effects of exercise on diabetes
lowers BG levels by inc. uptake of glucose in muscles, dec. risk for insulin resistance, reduces CV risks, improves muscle tone and circulation, dec. total cholesterol and triglycerides, assists in weight loss
Type 1 DM exercise rec.
20-40 min.; 4-7 days/wk
Type 2 DM exercise rec.
30 min. aerobic; 3 days/week
Exercise limitations for DM
no exercise if ketones found in urine; no prolonged exercise; if long period of activity, check BG before, during and after; no exercise w/in 1 hr of insulin or peak insulin action; eat 15g carb snack before; add additional 15-30 g carb snack for every additional 30-60 min.
methods of insulin admin.
subcu, IV
subcutaneous insulin
fastest absorption in abdomen, then thigh & butt; on regular schedule, sliding scale, or continuous infusion
IV insulin
IV push or continuous drip
oral hypoglycemics- types
sulfonylureas, biguanides, meglitinides, alpha-glucosidase inhibitors, TZDs
sulfonylureas- types
glyperide, glypizide, dolputamide
sulfonylureas- action
stimulates pancreas to release more insulin AND increases sensitivity of tissue to insulin (non-obese T2)
biguanides- type
metformin
biguanides- action
prevents liver from releasing more glucose AND increasing muscle cell insulin sensitivity
meglitinide- type
starlex
meglitinides- action
stimulates pancreatic cells to release more insulin
alpha-glucosidase inhibitors- action
slows intestinal digestion allowing increased time for carbohydrate absorption
TZDs- types
avandia and actos
TZDs- action
increased muscle cell insulin sensitivity
DM Client education topics
normal met., diabetes & met., diet, exercise, s/s of hyper-/hypo- glycemia, self administering, self-monitoring, foot care, sick days, community
Diabetic foot problems; source
abnormal pressure distribution or trauma s/t neuropathy, vascular disease w/diminished blood flow
Diabetic foot care
wash and inspect daily, file nails w/round corners, never go barefoot, test water temp w/hand, wear leather shoes w/cotton socks
Diabetic sick day goals
prevent dehydration, provide nutrition for recovery
Diabetic sick day management
monitor BG q3 or q4hr, continue insulin/meds, sip 8-12 oz. glucose fluid every hr., soft foods, rest- no exercise
Diabetic sick day; call MD if...
s/s of infection, illness >2 days, unable to eat >24 hr, vomiting/diarrhea >6 hrs, BG >400 two tests, urine + for glucose, ketones in urine >200
Increased risks for Diabetic surgery Pt
postop infection, delayed wound healing, fluid/electrolyte imbalance, hypoglycemia, DKA
Diabetic surgery
best met. state, regular insulin given w/IV glucose solution, 1/2 dose short-acting insulin preop, 1/2 dose PACU, oral hypoglycemics held 1-2 days preop, T2 may need perioperative insulin, early morning surgery, if NPO postop IV dextrose admin. on sliding scale
DM complications
hyper-/hypo-glycemia, dawn phenom., somogyi phenom., DKA, HHNK
describe hypoglycemia
BG<70; caused by mismatch of insulin or oral hypoglycemic, too much exercise, too little food
Mild hypoglycemia
40-60 BGL; sweating, tremor, tachycardia, palpitations, nervousness, hunger
Moderate hypoglycemia
20-40 BGL; h/a, lightheaded, double vision, drowsy, confused, numb lips/tongue, slurred speech
Severe hypoglycemia
BGL<20; disoriented, difficulty arousing from sleep, loss of consciousness, seizure
treatment of mild hypoglycemia
15 g CHO; 8 oz. milk, 4 oz. juice/soda, 5 hard candy, 3 marshmallows, 2-3 tsp sugar, 3-4 dextrose tabs; recheck 15 min., another snack if s/s persist
treat severe hypoglycemia
conscious; 15 g CHO fast-acting, simple; then d50% 10ml/min IV followed by D5W 10 g/hr
unconscious; glucagon 0.5-1 mg IM or subcu
describe hyperglycemia
BGL>200; caused by too little insulin or oral hypoglycemics, too much food, too little exercise, illness/stress
s/s of hyperglycemia
extreme thirst, hunger, freq. urination, blurred vision, drowsiness, nausea
describe Somogyi effect
fasting hyperglycemia; normal or high BGL @ bedtime, decreased BGL @ 2-3 am, followed by hyperglycemia caused by counter-reg. hormones
treatment of somogyi effect
decrease evening dose of insulin or increase bedtime snack
describe the Dawn phenomenon
fasting hyperglycemia; norm BGL, rise in BGL @ 3-4am, then glucose levels rise along w/ GH; differentiated from somogyi by taking BGL @ 3 (SE=hypo, DP=norm)
treatment of Dawn phenomenon
change time of evening insulin from dinnertime to bedtime
describe DKA
severe insulin deficiency in T1 DM clients; develops over several hrs/days
stages of DKA
1. hyperglycemia, 2. dehydration, 3. acidosis
DKA s/s
altered consciousness, kussmaul's resp., fruity breath, N/V, increased urine prod.
Lab findings for DKA
BSL = 300-800, inc. plasma ketones, urine ketones & glucose, ABGs= met. acidosis
treatment of DKA
fluid therapy, insulin drip, monitor/admin. electrolytes, EKG, hourly BG checks, assess vs, lungs, I/O, ketones
describe HHNK
slow onset of extreme hyperglycemia w/o ketosis/acidosis, found in T2 DM clients
s/s of HHNK
BSL= 600-2000, hypotension, tachycardia, extreme thirst; all r/t profound dehydration; altered LOC, neuro deficits, seizure, dry skin/mucous membranes
HHNK risks
stress, INFECTION, trauma, surgery, dehydration, TPN, drugs (thiazides, glucocorticoids, phenytoin)
chronic DM complications
atherosclerosis, PVD, inc. risk for CAD, CVD, PVD, retinopathy, nephropathy, neuropathy
prevalence of diabetic retinopathy
after 20 yrs of DM, almost all T1 DM, and 60% T2 DM
describe diabetic retinopathy
chronic progressive non-inflammatory impairment of retinal circulation, eventually causing hemorrhage, causing perm. vision changes to blindness
treatment for diabetic retinopathy
control HTN & BSL, photocoagulation, vitrectomy, cataract removal/lens implant
prevalence of diabetic nephropathy
20-40% DM Pts; leading cause of morbidity and mortality in DM
1st sign of nephropathy
microalbuminuria
other s/s nephropathy
thirst, fatigue, anemia, weight loss, freq. UTIs
treatment for diabetic nephropathy
control HTN & BSL, monitor vs, I/O, BUN, creatinine, restrict protein, Na, K, dialysis, kidney transplant
peripheral neuropathy- types
polyneuropathy, mononeuropathy
describe polyneuropathy
bilateral sensory disorder; most common; begins in foot/toes
describe mononeuropathy
effects a single nerve, unilateral
visceral/autonomic neuropathy
involves the ANS (GI, sexual performance, sweating, etc.)
s/s of polyneuropathy
distal parasthesias, pain, aching, burning, feelings of cold, altered/impaired sensation
s/s neuropathy
absent reflexes, pain in LE, poor peripheral pulses, N/V, diarrhea, incontinence, skin breakdown, skin infection, parasthesias
treatment of neuropathy
control HTN & BSL, foot care, pain meds, bladder training program
Norm BP range
systolic <120
diastolic <80
prehypertensive BP range
systolic 120-139 OR
diastolic 80-89
stage 1 HTN ranges
systolic 140-159 OR
diastolic 90-99
stage 2 HTN ranges
systolic >160 OR
diastolic >100
risks for essential HTN
aging, fam Hx, African American or Native American, obesity, smoking, stress
etiology for 2ndary HTN
renal disorder, cardiovascular disorders, endocrine disorders (cushings), neurogenic disorders (tumor), meds (glucocorticoids, estrogen)
s/s of HTN
asymptomatic, h/a, edema, pattern of consistently high BP
Dx of HTN
UA, BUN, creatinine, electrolytes, glucose, corticoids, ketosteroids, cholesterol, triglycerides, CXR, EKG
Tx of HTN
DASH diet, Na restriction, weight reduction, moderate alcohol intake, exercise, relaxation tech., avoid caffeine/smoking
Drugs types for HTN
diuretics, b-blockers, Ca channel blockers, ACE inhibitors, Angio II antagonists, aldosterone receptor antagonists
HTN crisis
>240/120; uncontrolled HTN, requires immediate reduction in BP, life-threatening; quick organ damage to kidneys, heart, and vasculature
s/s of HTN crisis
systolic >240, diastolic >120, h/a, drowsy, confused, tachycardia, tachypnea, cyanosis, numbness, tingling, seizure, motor impairment
HTN crisis nursing actions
semi-Fowler's, admin. O2, IV vasodilators (nitroprusside, nicardipine, labetalol), monitor BP q5-q15min until diastolic 75-90, then q30min, neuro assessments
acute PVD
caused by arterial thromobosis or embolism, abrupt onset, usually in younger adults
chronic PVD
peripheral atherosclerosis, insidious, usually older adults
thrombosis production
inc. coagulation, clot on vessel wall, infection/inflammation, pooling of blood
embolism production
colt floats through circulation, usually originating in the heart and lodged in smaller vessel
s/s arterial embolism/thrombus
sudden or insidious pain (distal to obstruction), numbness in extremity, pallor/mottling of extremity, cool/cold skin, pulselessness, paralysis, line of demarcation
Dx of arterial occlusion
arteriography (gold standard)
arterial occlusion management
meds: anticoagulants, thrombolytics; surgery: thrombectomy, emolectomy, thromboendarterectomy
arterial occlusion nursing actions
IV fluids, no hot/cold on extremities, bed cradle, extremity on same plane or lower than heart, no knee raising in bed, no 90-degree hip flexion, monitor pulses, color, pain, temp.
PAD
caused by atherosclerosis in ab. and iliac aorta, femoral or popliteal arteries or distal arteries, usually men in 60s, 70s, or 80s
s/s PAD
intermittent claudication, pain w/rest (burning), parasthesias, diminished peripheral pulses, pallor w/elevation, rubor w/dependency, thin, shiny hairless skin, thickened toenails, skin discoloration or breakdown
complications of PAD
gangrene, amputation, rupture of AAA, infection, sepsis
Dx PAD
doppler, transcutaneous oximetry, angiography
nursing actions for PAD
no smoking, limit caffeine, foot cradle, socks, slippers, position changes, avoid leg crossing and restrictive clothing, adapt exercise, pain meds, pain relief tech., keep feet warm and dependent position, inspect feet daily, foot care
PAD procedures
peripheral angioplasty, athrectomy, bypass grafting
bypass grafting nursing actions
assess 6 p's of ischemia, no hip/knee bends, 24 hr bedrest, hydrate/IV fluids
PAD meds
aspirin, plavix, ticlid, trental, pletal
Buerger's disease
thrombangitis obliterans; inflammation of medium and small arteries and veins of hands and feet
common Buerger's Pt
young, male smokers 20-40 y/o
s/s of Buerger's
intermittent claudication in arch of foot, sensitivity to cold, numbness, diminished pulses, red/cyanotic extremities when dependent, ulcerations
management of Buerger's
stop smoking, prevent vasoconstriction, improve peripheral pulses, prevent complications
Raynaud's disease
vasospasms of small arteries of UE or LE, mostly in hands; white-blue-red
s/s Raynaud's
numbness, tingling, stiffness, decreased sensation, aching, pallor then cyanosis then rubor
management of Raynaud's
avoid triggers (cold), wear warm clothing, avoid injuries to fingers/hands, Ca channel blockers, muscle relaxants, vasodilators
aneurysm
localized dilation or outpouching or an artery
major risk for aneurysm
atherosclerosis
aneurysm management
control BP w/antihypertensives to prevent rupture
Berry aneurysm
@ circle of willis
Dx aneurysm
CXR, ab. ultrasound, TEE, tomography, MRI, angiography
s/s of aortic dissection
ripping/tearing pain, pallor, sweating, tachycardia, diff. BP in each arm, LE paralysis, SHOCK
ways to prevent aneurysm rupture
bedrest, legs flat/avoid crossing, calm environment, avoid valsalva's (stool softeners, avoid reaching, lift team), antihypertensives, monitor EKG, vs, I/O
operable size for aneurysm
thoracic: >6cm
abdominal: >5cm
surgical procedures for aneurysm
open procedure (graft), endovascular stent graft
postop aneurysm surgery complications
renal failure, graft occlusion, resp. distress, arrhythmia, paralytic ileus, sepsis
post aneurysm repair nursing actions
colloids, IV fluids, monitor vs, perfusion distal to graft, resp., NG tube, DVT prophylaxis, avoid valsalva's
venous disorders
venous occlusion, ineffective venous bloodflow (stasis, clotting, congestion)
risks for venous thrombosis
immobile, surgery, cancer, trauma, pregnancy, hormone therapy, coagulation disorder
DVT
dull aching pain in extremity, cyanosis, elevated temp., malaise
Dx thrombophlebitis
venogram, MRI, doppler
thrombophlebitis meds
anticoagulants, antiplatelets, thrombolytics, analgesics
thrombophlebitis nursing actions
pain relief, decrease edema, prevent ulceration (bed cradle), bedrest, no massage, monitor meds, hr, resp.
thrombophlebitis surgical interventions
venous thrombectomy, vena cava filter, ligation, plication
norm Na levels
135-148
norm K levels
3.4-5.3
norm BUN
3-29
norm WBCs
3.8-10.8